The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts

Journal of Thrombosis and Thrombolysis
Philipp DiehlStephan Winnik

Abstract

Sirtuin 3 is a nicotinamide adenine dinucleotide dependent mitochondrial deacetylase that governs mitochondrial metabolism and oxidative defense. The demise in myocardial function following myocardial ischemia has been associated with mitochondrial dysfunction. Sirt3 maintains myocardial contractile function and protects from cardiac hypertrophy. The role of Sirt3 in ischemia is controversial. Our objective was to understand, under what circumstances Sirt3 is protective in different facets of ischemia, using an in vitro proof-of-concept approach based on simulated ischemia in cultured cardiomyoblasts. Cultured H9c2 cardiomyoblasts were subjected to hypoxia and/or serum deprivation, the combination of which we refer to as simulated ischemia. Apoptosis, as assessed by Annexin V staining in life-cell imaging and propidium-iodide inclusion in flow cytometry, was enhanced following simulated ischemia. Interestingly, serum deprivation was a stronger trigger of apoptosis than hypoxia. Knockdown of Sirt3 further increased apoptosis upon serum deprivation, whereas no such effect occurred upon additional hypoxia. Similarly, only upon serum deprivation but not upon simulated ischemia, silencing of Sirt3 led to a deterioration of mitochond...Continue Reading

References

Aug 26, 1998·Cardiovascular Research·H M PiperM Ovize
Jan 12, 2005·Circulation·Laurent ArgaudMichel Ovize
Mar 26, 2005·Investigative Ophthalmology & Visual Science·Irma CharlesNeeraj Agarwal
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Bong-Hyun AhnToren Finkel
Aug 5, 2009·The Journal of Clinical Investigation·Nagalingam R SundaresanMahesh P Gupta
Nov 18, 2010·In Vitro Cellular & Developmental Biology. Animal·Sarah J WatkinsHelen M Arthur
Jan 18, 2012·Nature Reviews. Endocrinology·Angeliki Chalkiadaki, Leonard Guarente
Mar 8, 2012·Nature Reviews. Molecular Cell Biology·Riekelt H HoutkooperJohan Auwerx
Aug 8, 2012·Journal of the American College of Surgeons·Michael P RobichFrank W Sellke
Dec 4, 2012·Biochemical and Biophysical Research Communications·Chun-Juan ChenWei Wang
Apr 22, 2014·American Journal of Physiology. Heart and Circulatory Physiology·George A PorterSergiy M Nadtochiy
Mar 18, 2015·Journal of Cellular and Molecular Medicine·Heng ZengJian-Xiong Chen
Apr 17, 2015·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Mohsen Sharifi KlishadiFatemeh Safari
May 13, 2015·Basic Research in Cardiology·Christoph KoentgesHeiko Bugger
Jun 27, 2015·European Heart Journal·Stephan WinnikChristian M Matter
Nov 3, 2015·Canadian Journal of Physiology and Pharmacology·Christoph KoentgesHeiko Bugger
Mar 5, 2016·Nature Reviews. Cardiology·Boback Ziaeian, Gregg C Fonarow

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.